MedTrace Logo

Cloud-Based Mapping for Personalized Ablation

NCT04127123 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-05-07

No results posted yet for this study

Summary

Atrial fibrillation is a serious public health issue that affects over 5 million Americans in whom it may cause skipped beats, dizziness, stroke and even death. This study seeks to improve our understanding of the causes of atrial fibrillation and to design new and more effective therapy for this heart rhythm disorder.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Sanjiv Narayan, MD, PhD · Stanford University

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-03
Primary Completion
2020-12-30
Completion
2021-01-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04127123 on ClinicalTrials.gov